Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

Autor: Van Coevorden, Frits, Vanhoutvin, Steven, Hulshof, Maarten CCM, Loosveld, Olaf JL, Ten Tije, A (Bert) Jan, Erdkamp, Frans LG, Warmerdam, Fabienne ARM, Van der Peet, Donald L, Verheul, Henk MW, Boerma, Djamila, Los, Maartje, Slot, Annerie, Houtsma, Danny, Portielje, Johanna EA, Blaisse, Reinoud JB, Spillenaar Bilgen, Ernst Jan, Polée, Marco B, Geenen, Maud M, Braak, Jeffrey PBM, Neelis, Karen J, Slingerland, Marije, Jansen, Rob LH, Buijsen, Jeroen, Beeker, Aart, Eijsbouts, Quirijn AJ, Van Riel, Johanna MGH, Rozema, Tom, Van Spronsen, Dick Johan, Meerum Terwogt, Jetske M, Tanis, Bea C, Van der Torren-Conze, Adelheid ME, Van Hilligersberg, Richard, Koopman, Miriam, Den Boer, Marien O, Creemers, Geert-Jan, Van der Sangen, Maurice, Rentinck, Marjolein EM, Van den Berg, H Pieter, Jonkers, Ge JPM, Grootenboers, Diane, Vulink, Annelie JE, Hovenga, Sjoerd, Van der Mijle, Huub CJ, Baars, Arnold, Haringhuizen, Annebeth W, Appels, Marije IE, Rietbroek, Ron C, Hendriksen, Ellen M, Legdeur, Marie-Cecile JC, Ten Bokkel Huinink, Daan, Van Dobbenburgh, O Aart, Smit, Jitty M, Van Bochove, Aart, Veldhuis, Gerrit-Jan, Muller, Erik W, Bonenkamp, J (Han) J, Braam, Pètra M, De Boer, Jaap, Van Halteren, Henk K, Valster, Fransje AA, Imholz, Alex LT, Van Dijk, Marjan A, Van der Gaast, Ate, Otten, J (Hans)-Martin MB, Ceha, Heleen M, Glimelius, Bengt, Lagerbäck, Cecillia, Perman, Mats, Johnsson, Anders, Borg, David, Nielsen, Niels H, Piwowar, Andrzej, Elmlund, Mattias, Hörberg, Helene, Edlund, Per, Johansson, Bengt, Flygare, Petra, Jespersen, Marie Louise, Cats, Annemieke, Jansen, Edwin P M, van Grieken, Nicole C T, Sikorska, Karolina, Lind, Pehr, Nordsmark, Marianne, Meershoek-Klein Kranenbarg, Elma, Boot, Henk, Trip, Anouk K, Swellengrebel, H A Maurits, van Laarhoven, Hanneke W M, Putter, Hein, van Sandick, Johanna W, van Berge Henegouwen, Mark I, Hartgrink, Henk H, van Tinteren, Harm, van de Velde, Cornelis J H, Verheij, Marcel

Publikováno v: In The Lancet Oncology May 2018 19(5):616-628

Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission

Autor: Hamer, Henrike M., Jonkers, Daisy M.A.E., Vanhoutvin, Steven A.L.W., Troost, Freddy J., Rijkers, Ger, de Bruïne, Adriaan, Bast, Aalt, Venema, Koen, Brummer, Robert-Jan M.

Publikováno v: In Clinical Nutrition 2010 29(6):738-744

Bevacizumab combined with docetaxel, oxaliplatin, and capecitabine, followed by maintenance with capecitabine and bevacizumab, as first-line treatment of patients with advanced HER2-negative gastric cancer: A multicenter phase 2 study

Autor: Meulendijks, Didier, De Groot, Jan Willem B, Los, Maartje, Boers, James E., Beerepoot, Laurens V., Polee, Marco B., Beeker, Aart, Portielje, Johanna E A, Goey, Swan H., De Jong, Robert S., Vanhoutvin, Steven A L W, Kuiper, Maria, Sikorska, Karolina, Pluim, Dick, Beijnen, Jos H., Schellens, Jan H M, Grootscholten, Cecile, Tesselaar, Margot E T, Cats, Annemieke, Sub Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology

Publikováno v: Cancer, 122(9), 1434. John Wiley and Sons Inc.

The current study was a multicenter, single-arm, phase 2 study performed to investigate the feasibility and efficacy of bevacizumab combined with docetaxel, oxaliplatin, and capecitabine (B-DOC) in patients with advanced human epidermal growth factor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70621c38d13679c92ef58a086cb106b3
https://doi.org/10.1002/cncr.29864

Trastuzumab and bevacizumab combined with docetaxel, oxaliplatin and capecitabine as first-line treatment of advanced HER2-positive gastric cancer: a multicenter phase II study

Autor: Meulendijks, Didier, Beerepoot, Laurens V., Boot, Henk, de Groot, Jan Willem B, Los, Maartje, Boers, James E., Vanhoutvin, Steven A L W, Polee, Marco B., Beeker, Aart, Portielje, Johanna E A, de Jong, Robert S., Goey, Swan H., Kuiper, Maria, Sikorska, Karolina, Beijnen, Jos H., Tesselaar, Margot E., Schellens, Jan H M, Cats, Annemieke

Summary: Objective To investigate the efficacy of bevacizumab and trastuzumab combined with docetaxel, oxaliplatin, and capecitabine (B-DOCT) as first-line treatment of advanced human epidermal growth factor receptor 2 (HER2)-positive gastric cancer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______101::249ed98d1dbd435c83166eb0257c2704
https://dspace.library.uu.nl/handle/1874/330130

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.